India searches premises of cough syrup maker linked to child deaths
Summary
India's financial crime agency is searching seven sites linked to Sresan Pharma over money laundering suspicions following children's deaths from toxic cough syrup in Madhya Pradesh.
Key Points
- India's financial crime agency is investigating Sresan Pharma for money laundering related to toxic cough syrup linked to child deaths.
- At least 19 children died in Madhya Pradesh after consuming cough syrup containing toxic chemical diethylene glycol at unsafe levels.
- The cough syrup involved was sold domestically, while India enforces more stringent export testing for syrups after earlier international deaths.
- Two other syrups, Respifresh and RELIFE, also tested positive for the toxic chemical and are now under scrutiny.
- Searches included homes of top officials in Tamil Nadu's drug control office, reflecting concerns about regulatory oversight.
